XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue [Abstract]  
REVENUE

14. REVENUE

 

We primarily offer the First DefenseÒ product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the three-month or six-month periods ended June 30, 2024 or 2023. We do not have any contract assets for which we have satisfied the performance obligations, but do not yet have the right to bill for, or contract liabilities such as customer advances. All trade receivables on our balance sheet are from contracts with customers. We incur no material costs to obtain contracts.

 

The following table presents our product sales disaggregated by geographic area:

 

   During the Three-Month
Periods Ended June 30,		   During the Six-Month
Periods Ended June 30,		 
   2024   %   2023   %   2024   %   2023   % 
United States  $4,892,136    89%  $3,254,266    92%  $11,232,777    88%  $6,250,420    90%
Other   580,754    11%   278,415    8%   1,497,690    12%   728,787    10%
Total Product Sales  $5,472,890    100%  $3,532,681    100%  $12,730,467    100%  $6,979,207    100%

 

The following table presents our product sales disaggregated by major product category:

 

   During the Three-Month
Periods Ended June 30,		   During the Six-Month
Periods Ended June 30,		 
   2024   %   2023   %   2024   %   2023   % 
First Defense® product line  $5,430,069    99%  $3,482,259    99%  $12,650,710    99%  $6,893,491    99%
Other animal health   42,821    1%   50,422    1%   79,757    1%   85,716    1%
Total Product Sales  $5,472,890    100%  $3,532,681    100%  $12,730,467    100%  $6,979,207    100%